Skip to main content
SpringerLink
Log in

Adult medulloblastoma: clinical characters, prognostic factors, outcomes and patterns of relapse

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To analyze the clinical characters, prognostic factors, patterns of relapse and treatment outcomes for medulloblastoma in adults. The clinical materials of 73 consecutive adult patients (age, ≥16 years) with medulloblastoma were analyzed retrospectively. Follow-up data were available in 62 patients, ranging from 10 to 142 months (median, 78.4 months). Outcome in survival was assessed by the progression-free survival (PFS) and overall survival (OS). Univariate and multivariate analysis were performed to determine the prognostic factors. Total or near-total tumor resection was achieved in 37 cases (59.7 %), subtotal in 19 cases (30.6 %), and partial resection in 6 cases (9.7 %).Twenty-two patients experienced recurrences, and 45 % percent of all recurrences occurred more than 4 years after initial surgery. The PFS rates at 5 and 8 years were 60.1 and 37.0 %, respectively. The OS rates at 5 and 8 years were 82.6 and 57.3 %, respectively. In univariate analysis, less tumor resection, non-desmoplastic pathology, and brainstem involvement were risk factors for worse PFS and OS (P < 0.05). High-risk category was associated with just lower PFS, but not OS. In multivariate analysis, complete resection and desmoplastic pathology were independently predictive factors of improved PFS and OS. In adult medulloblastoma, late relapse is common and therefore long-term follow-up is important for evaluating the real impact of treatments. Risk category had prognostic value just for PFS, but not for OS. Complete resection and desmoplastic histology are independently predictive factors for favorable outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A (2002) Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 54:855–860

    Article  PubMed  Google Scholar 

  2. Carrie C, Lasset C, Blay JY, Négrier S, Bouffet E, Barbet N, Montbarbon X, Wagner JP, Lapras C, Deruty R et al (1993) Medulloblastoma in adults: survival and prognostic factors. Radiother Oncol 29:301–307

    Article  CAS  PubMed  Google Scholar 

  3. Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A (1999) Epidemiology of adult medulloblastoma. Int J Cancer 80:689–692

    Article  CAS  PubMed  Google Scholar 

  4. Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH (1997) Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 3:238–245

    CAS  PubMed  Google Scholar 

  5. Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M (2007) Longterm results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110(9):2035–2041

    Article  PubMed  Google Scholar 

  6. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 93:1351–1359

    Article  CAS  PubMed  Google Scholar 

  7. Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARC Press, Lyon

    Google Scholar 

  8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. IARC Press, Lyon

    Google Scholar 

  9. Brandes AA, Franceschi E, Tosoni A, Reni M, Gatta G, Vecht C, Kortmann RD (2009) Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol 71(2):165–179

    Article  PubMed  Google Scholar 

  10. Chargari C, Feuvret L, Levy A, Lamproglou I, Assouline A, Hemery C, Ghorbal L, Lopez S, Tep B, G GB, Lang P, Laigle-Donadey F, Cornu P, Mazeron JJ, Simon JM (2010) Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse. Br J Neurosurg 24:460–467

  11. Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, Chapman P, Loeffler JS (2000) Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 47:623–633

    CAS  PubMed  Google Scholar 

  12. Khalil EM (2008) Treatment results of adults and children with medulloblastoma NCI, Cairo University experience. J Egypt Natl Canc Inst 20:175–186

    PubMed  Google Scholar 

  13. Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C; French Society of Paediatric Oncology (2005) Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6:573–580

    Article  Google Scholar 

  14. Mueller S, Chang S (2009) Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics 6:570–586

    Article  CAS  PubMed  Google Scholar 

  15. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845

    CAS  PubMed  Google Scholar 

  16. Brandes AA, Ermani M, Amista P, Basso U, Vastola F, Gardiman M, Iuzzolino P, Turazzi S, Rotilio A, Volpin L, Mazza C, Sainati L, Ammannati F, Berti F (2003) The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys 57:755–761

    Article  PubMed  Google Scholar 

  17. Carrie C, Lasset C, Alapetite C, Haie-Meder C, Hoffstetter S, Demaille MC, Kerr C, Wagner JP, Lagrange JL, Maire JP et al (1994) Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer 74:2352–2360

    Article  CAS  PubMed  Google Scholar 

  18. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 252:291–299

    Article  PubMed  Google Scholar 

  19. Brandes AA, Palmisano V, Monfardini S (1999) Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev 25:3–12

    Article  CAS  PubMed  Google Scholar 

  20. Brandes AA, Paris MK (2004) Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol 50:121–128

    Article  PubMed  Google Scholar 

  21. Kortmann RD, Brandes AA (2003) Current and future strategies in the management of medulloblastoma in adults. Forum (Genova) 13:99–110

    CAS  Google Scholar 

  22. Kortmann RD, Kuhl J, Timmermann B, Calaminus G, Dieckmann K, Wurm R, Sörensen N, Urban C, Göbel U, Bamberg M (2001) Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranialgerm cell tumors in childhood. Strahlenther Onkol 177:447–461

    Article  CAS  PubMed  Google Scholar 

  23. del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB Jr (1998) Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 42:147–154

    PubMed  Google Scholar 

  24. Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Kofide A, Mustafa M, Schultz H (2000) Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 47:573–584

    Article  CAS  PubMed  Google Scholar 

  25. Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK (1995) Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology(SIOP) and the (German) Society of Paediatric Oncology (GPO):SIOP II. Med Pediatr Oncol 25(3):166–178

    Article  CAS  PubMed  Google Scholar 

  26. Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS, International Society of Paediatric Oncology, United Kingdom Children’s Cancer Study Group (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study. J Clin Oncol 21:1581–1591

    Article  Google Scholar 

  27. Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T (2008) Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer 51:603–607

    Article  PubMed  Google Scholar 

  28. Kunschner LJ, Kuttesch J, Hess K, Yung WK (2001) Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol 3:167–173

    PubMed Central  CAS  PubMed  Google Scholar 

  29. Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T (2009) Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111(3):478–487

    Article  PubMed  Google Scholar 

  30. Lai R (2008) Survival of patients with adult medulloblastoma: a population-based study. Cancer 112:1568–1574

    Article  PubMed  Google Scholar 

  31. Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C (2007) Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68:433–440

    Article  PubMed  Google Scholar 

  32. Menon G, Krishnakumar K, Nair S (2008) Adult medulloblastoma: clinical profile and treatment results of 18 patients. J Clin Neurosci 15:122–126

    Article  PubMed  Google Scholar 

  33. Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer 49:893–903

    Article  PubMed  Google Scholar 

  34. Prados MD, Warnick RE, Wara WM, Larson DA, Lamborn K, Wilson CB (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:1145–1152

    Article  CAS  PubMed  Google Scholar 

  35. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R (2012) Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 30(26):3187–3193

    Article  PubMed  Google Scholar 

  36. Fellay CN, Frappaz D, Sunyach MP, Franceschi E, Brandes AA, Stupp R (2011) Medulloblastomas in adults: prognostic factors and lessons from paediatrics. Curr Opin Neurol 24(6):626–632

    Article  PubMed  Google Scholar 

  37. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3(8):e3088

    Article  PubMed Central  PubMed  Google Scholar 

  38. Northcott PA, Hielscher T, Dubuc A, Mack S, Shih D, Remke M, Al-Halabi H, Albrecht S, Jabado N, Eberhart CG, Grajkowska W, Weiss WA, Clifford SC, Bouffet E, Rutka JT, Korshunov A, Pfister S, Taylor MD (2011) Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol 122(2):231–240

    Article  PubMed Central  PubMed  Google Scholar 

  39. Al-Halabi H, Nantel A, Klekner A, Guiot MC, Albrecht S, Hauser P, Garami M, Bognar L, Kavan P, Gerges N, Shirinian M, Roberge D, Muanza T, Jabado N (2011) Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol 121(2):229–239

    Article  PubMed  Google Scholar 

  40. McManamy CS, Pears J, Weston CL, Hanzely Z, Ironside JW, Taylor RE, Grundy RG, Clifford SC, Ellison DW, Clinical Brain Tumour Group (2007) Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17:151–164

    Article  Google Scholar 

  41. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978–986

    Article  CAS  PubMed  Google Scholar 

  42. de Haas T, Hasselt N, Troost D, Caron H, Popovic M, Zadravec-Zaletel L, Grajkowska W, Perek M, Osterheld MC, Ellison D, Baas F, Versteeg R, Kool M (2008) Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression. Clin Cancer Res 14:4154–4160

    Article  PubMed  Google Scholar 

  43. Johnston DL, Keene D, Bartels U, Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L, Larouche V, Moghrabi A, Wilson B, Zelcer S, Silva M, Brossard J, Bouffet E (2009) Medulloblastoma in children under the age of three years: a retrospective Canadian review. J Neurooncol 94:51–56

    Article  PubMed  Google Scholar 

  44. Kortmann RD, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT ‘91. Int J Radiat Oncol Biol Phys 46(2):269–279

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Avenue No. 1095, Wuhan, 430030, Hubei, China

    Na Zhang, Huicong Kang & Suiqiang Zhu

  2. Department of Neurosurgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

    Taohui Ouyang & Wang Long

  3. Department of Neurosurgery, Port Moresby General Hospital, University of Papua New Guinea, Port Moresby, Papua New Guinea

    Benjamin Thomas

Authors
  1. Na Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taohui Ouyang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huicong Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wang Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Benjamin Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suiqiang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suiqiang Zhu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, N., Ouyang, T., Kang, H. et al. Adult medulloblastoma: clinical characters, prognostic factors, outcomes and patterns of relapse. J Neurooncol 124, 255–264 (2015). https://doi.org/10.1007/s11060-015-1833-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-1833-y

Keywords

Search

Navigation